THE EFFECT OF MITOMYCIN-C ON SUPERFICIAL BLADDER-CANCER

被引：62
|
作者：
SOLOWAY, MS
MURPHY, WM
DEFURIA, MD
CROOKE, S
FINEBAUM, P
机构：
[1] BAPTIST MEM HOSP,DEPT PATHOL,MEMPHIS,TN 38146
[2] BRISTOL MYERS CO LABS,DEPT CLIN RES,SYRACUSE,NY 13201
来源：
JOURNAL OF UROLOGY | 1981年 / 125卷 / 05期
关键词：
D O I：
10.1016/S0022-5347(17)55149-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：646 / 648
页数：3
相关论文
共 50 条
  • [31] PROPHYLACTIC INSTILLATION THERAPY OF SUPERFICIAL BLADDER-CANCER - A RANDOMIZED STUDY COMPARING MITOMYCIN-C AND ADRIAMYCIN WITH SPECIAL REFERENCE TO DNA PLOIDY
    GUSTAFSON, H
    WIJKSTROM, H
    NYMAN, C
    BROLIN, J
    BORGSTROM, E
    TRIBUKAIT, B
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1991, : 187 - 191
  • [32] ENHANCED LETHALITY BY METHYLXANTHINES IN HUMAN BLADDER-CANCER CELLS TREATED WITH THIOTEPA OR MITOMYCIN-C
    FINGERT, HJ
    ALLEY, MC
    LIEBER, MM
    PARDEE, AB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 354 - 354
  • [33] COMBINATION CHEMOTHERAPY WITH CISPLATINUM, ADRIAMYCIN, MITOMYCIN-C (PAM) IN PATIENTS WITH ADVANCED BLADDER-CANCER
    KOSMIDIS, PA
    BACOYIANNIS, C
    HATZICHRISTOU, H
    JOURNAL OF CHEMOTHERAPY, 1990, 2 (06) : 397 - 400
  • [34] TOPICAL MITOMYCIN-C (MMC) IN THIOTEPA REFRACTORY NON-INVASIVE BLADDER-CANCER
    ISSELL, BF
    DEFURIA, MD
    FANDRICH, SE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 464 - 464
  • [35] CHARACTERIZATION OF A HUMAN BLADDER-CANCER CELL-LINE SELECTED FOR RESISTANCE TO MITOMYCIN-C
    XU, BH
    GUPTA, V
    SINGH, SV
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (05) : 686 - 692
  • [36] MECHANISM OF DIFFERENTIAL SENSITIVITY OF HUMAN BLADDER-CANCER CELLS TO MITOMYCIN-C AND ITS ANALOG
    XU, BH
    GUPTA, V
    SINGH, SV
    BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 242 - 246
  • [37] A RANDOMIZED STUDY OF SINGLE DOSE INTRAVESICAL MITOMYCIN-C IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER
    Ferakis, N.
    Granitsas, T.
    Bouropoulos, C.
    Arvanitis, I
    Charalampogiannis, N.
    Nikolaou, N.
    Farmakis, A.
    Poulias, I
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 594 - 594
  • [38] INTRAVESICAL COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C AND DOXORUBICIN FOR SUPERFICIAL BLADDER-CANCER - A RANDOMIZED TRIAL OF MAINTENANCE VERSUS NO MAINTENANCE FOLLOWING A COMPLETE RESPONSE
    FUKUI, I
    KIHARA, K
    SEKINE, H
    TACHIBANA, Y
    KAWAI, T
    ISHIWATA, D
    OSHIMA, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 : S37 - S40
  • [39] INTRAVESICAL MITOMYCIN-C FOR THE TREATMENT OF RECURRENT SUPERFICIAL BLADDER-TUMORS
    HETHERINGTON, JW
    NEWLING, DWW
    ROBINSON, MRG
    SMITH, PH
    ADIB, RS
    WHELAN, P
    BRITISH JOURNAL OF UROLOGY, 1987, 59 (03): : 239 - 241
  • [40] ROLE OF INTRAVESICAL MITOMYCIN-C IN MANAGEMENT OF SUPERFICIAL BLADDER-TUMORS
    BRACKEN, RB
    JOHNSON, DE
    ESCHENBACH, ACV
    SWANSON, DA
    DEFURIA, D
    CROOKE, S
    UROLOGY, 1980, 16 (01) : 11 - 15
12345